How Not to Die — Michael Greger

Dr. Michael Greger's How Not to Die is an exhaustive review of the peer-reviewed evidence on how diet influences chronic disease — cardiovascular disease, autoimmune conditions, inflammation, and the deterioration of nearly every major organ system. For patients managing dysautonomia, POTS, ME/CFS, or MCAS, the book is relevant not as a cure but as a rigorous account of how what you eat either amplifies or reduces the inflammatory and vascular burden these conditions already impose.

Why Diet Matters in Dysautonomia

Dysautonomia is fundamentally a regulatory failure — the autonomic nervous system isn't coordinating blood flow, vascular tone, heart rate, and blood pressure accurately enough during the demands of upright posture and daily activity. That regulatory architecture doesn't operate in isolation. It operates inside a body whose baseline inflammatory state, blood volume, vascular health, and immune activity either support or undermine its function at every moment.

Chronic systemic inflammation narrows the margin. It degrades vascular endothelial function, which means blood vessels respond less precisely to autonomic signals. It impairs mitochondrial efficiency, which means the energy cost of compensation is higher. It activates immune pathways that interact with autonomic regulation directly. In conditions like MCAS, where mast cell activation is itself the central problem, diet becomes a primary variable — not because food causes the condition, but because specific foods trigger mast cell degranulation and others don't.

What Greger Covers

The book is organized by disease category — cardiovascular disease, diabetes, cancer, autoimmune disease, and others — with each chapter reviewing the evidence on dietary patterns that increase or reduce risk. Greger draws from an enormous volume of peer-reviewed research, citing studies throughout, and his position is unambiguous: a whole-food, plant-based diet reduces systemic inflammation and disease burden across nearly every category he examines.

For dysautonomia patients specifically, the most directly relevant sections are the cardiovascular chapters. Blood vessel health, endothelial function, blood viscosity, and nitric oxide production — all of which influence how well the vasculature responds to autonomic signaling — are directly affected by diet. The research Greger cites on how specific foods raise or lower inflammatory markers has practical implications for anyone whose condition involves vascular dysregulation.

The Sodium Question

One tension worth naming: standard POTS and dysautonomia management often involves high sodium intake to expand blood volume. Greger's cardiovascular chapters make a strong evidence-based case against high sodium for cardiovascular risk. These are not necessarily contradictory positions — the mechanism of sodium loading in POTS is specific and the patient population is different from those in the cardiovascular studies — but it is a tension patients and clinicians should think through rather than ignore. High sodium is a tool for a specific physiological problem; Greger's evidence applies to a different context. Both can be true.

How to Read It

Greger writes accessibly and with clear advocacy for his position. He is a physician and researcher but this is not a neutral textbook — it has a point of view. Read it as a well-sourced argument rather than a final answer, particularly where his recommendations intersect with condition-specific protocols. The underlying research he cites is real and worth engaging with. The practical recommendations should be filtered through your own clinical picture.

For conditions like MCAS where dietary triggers are central to daily management, this book provides a useful framework for thinking about food as a variable in inflammatory load. For POTS and ME/CFS patients navigating the relationship between nutrition and energy availability, the sections on mitochondrial function and oxidative stress are particularly worth reading.